2 assets in Postmenopausal Osteoporosis

Therapeutic assets addressing Postmenopausal Osteoporosis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Denosumab Postmenopausal Osteoporosis	Aristotle University Of Thessaloniki	P4	B (63)
Alendronic Acid Postmenopausal Osteoporosis	Aristotle University Of Thessaloniki	P4	B (62)